Science
AlloHCT
Moazzam Shahzad/researchgate.net

Moazzam Shahzad Shares New Insights on AlloHCT in Elderly Myelofibrosis Patients

Moazzam Shahzad, Hematologist-Oncologist at H. Lee Moffitt Cancer Center and Research Institute, shared a post on X about a paper published on Clinical Lymphoma, Myeloma and Leukemia:

“Our latest publication in CLML explores alloHCT outcomes in elderly myelofibrosis patients.”

Title: Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above with Myelofibrosis

Authors: Moazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, Rania Ahsan, Hana Qasim, Muhammad Jawad Javed, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Read the full article.

AlloHCT

More posts featuring Moazzam Shahzad on OncoDaily.

Abdulraheem Yacoub alloHCT Anurag K. Singh cancer CLML Hana Qasim Iqra Anwar Joseph P. McGuirk Matthew McGuirk Mehdi Hamadani Moazzam Shahzad Muhammad Jawad Javed Muhammad Kashif Amin Muhammad Umair Mushtaq myelofibrosis OncoDaily Oncology Rania Ahsan Sibgha Gull Chaudhary Sohaib Irfan